Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,597.00

Bid: 1,596.00

Ask: 1,597.00

Change: -7.50 (-0.47%)

Spread: 1.00 (0.063%)

Open: 1,613.00

High: 1,613.00

Low: 1,595.50

Prev. Close: 1,604.50

Last checked at -

UK Earnings, Trading Statements Calendar - Week Ahead

Wed, 23rd Apr 2014 15:29

UK Earnings, Trading Statements Calendar
Thursday, April 24
AZ Electronic Materials	Interim Management Statement
Berendsen	Interim Management Statement
Pace	Interim Management Statement
Henderson Group	Interim Management Statement
AstraZeneca	Q1 Results
Trap Oil	Full Year Results
PuriCore	Full Year Results
African Barrick Gold	Q1 Results
Anglo American	Interim Management Statement
Anglo Platinum	Interim Management Statement
Premier Foods	Interim Management Statement
Computacenter	Interim Management Statement
Camellia	Full Year Results
Elementis	Interim Management Statement
Cobham	Interim Management Statement
Croda International	Interim Management Statement
Mecom Group	Interim Management Statement
Molins	Interim Management Statement
Senior	Interim Management Statement
Spirit Pub Company	Full Year Results
Unilever	Q1 Results
Delphi Automotive	Q1 Results
Travis Perkins	Interim Management Statement
Friday, April 25
William Hill	Interim Management Statement
Aon	Q1 Results
Colt	Interim Management Statement
WPP	Trading Statement
Spectris	Interim Management Statement
Harvey Nash	Full Year Results
Rotork	Interim Management Statement
Senior	Interim Management Statement
Egdon	Half Year Results
Monday, April 28
No Events Scheduled
Tuesday, April 29
Heathrow Airport Holdings Limited	Q1 Results
AB Dynamics	Half Year Results
Petropavlovsk	Full Year Results
Foreign & Colonial Investment Trust	Interim Management Statement
Lidco	Full Year Results
Segro	Interim Management Statement
UBM	Interim Management Statement
Essentra	Interim Management Statement
Huntsworth	Full Year Results
St James's Place	Interim Management Statement
Carphone Warehouse	Trading Statement
Ensco	Q1 Results
Jardine Lloyd Thompson Group	Interim Management Statement
Telecity Group	Interim Management Statement
BP	Q1 Results
Utilitywise	Full Year Results
Carphone Warehouse Group	Trading Update
Redrow	Interim Management Statement
Stagecoach	Trading Update
Lifeline	Full Year Results
Walker Greenbank	Full Year Results
JQW	Full Year Results
Flying Brands	Full Year Results
Wednesday, April 30
Glaxosmithkline	Q1 Results
Globo	Full Year Results
Ladbrokes	Interim Management Statement
Home Retail Group	Full Year Results
Standard Life	Trading Statement
International Personal Finance.	Interim Management Statement
kazakhmys	Interim Management Statement
SVG Capital	Interim Management Statement
DS Smith	Pre-close Statement
Ultra Electronics	Interim Management Statement
Avon Rubber	Full Year Results
Superglass Holdings	Full Year Results
CSR	Q1 Results
Next	Interim Management Statement
Tullow Oil	Interim Management Statement
Greggs	Interim Management Statement
Panther Securities	Full Year Results
Camellia	Full Year Results
Playtech	Interim Management Statement
Talvivaara	Full Year Results

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News

17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Login to your account

Quickpicks are a member only feature

Login to your account